CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2011; 32(02): 105-108
DOI: 10.4103/0971-5851.89794
CASE REPORT

Embryonal carcinoma in androgen insensitivity syndrome

Debabrata Barmon
Department of Gynecologic Oncology, Dr. B. Borooah Cancer Institute, Guwahati, India
,
Amal Chandra Kataki
Department of Gynecologic Oncology, Dr. B. Borooah Cancer Institute, Guwahati, India
,
J D Sharma
Department of Pathology, Dr. B. Borooah Cancer Institute, Guwahati, India
,
Rahman Hafizur
Department of O&G, Sikkim Manipal Institute of Medical Sciences, Sikkim, India
› Author Affiliations
Source of Support Nil.

Abstract

Embryonal cell carcinoma is a rare clinical entity. We report a case of a 20-year-old patient who presented with lump lower abdomen for last two months with primary amenorrhea and poorly developed secondary sexual characteristics. Ultrasonography (USG) whole abdomen showed lower abdominal mass approximately 15΄15΄10 cm, probably neoplastic changes in intra-abdominal testis, with mild ascites, no uterus and ovaries. Fine needle aspiration cytology from the tumor mass reported the possibility of non-seminomatous germ cell tumor, possibly embryonal carcinoma. The patient received three cycles of neo-adjuvant chemotherapy (Regime Bleomycin, Etoposide and Cisplatin) followed by laparotomy, at laparotomy (L) orchidectomy with removal of tumor, (R) orchidectomy, omentectomy and appendisectomy was performed. Postoperatively the patient received two more cycles of chemotherapy of the same regime. The patient has been under close follow-up for the last three years with no evidence of disease.



Publication History

Article published online:
06 August 2021

© 2011. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Stenchevr MA, Jones GK, Jarvis JA. Testicular feminization syndrome: Chromosomal, histologic and genetic studies in a large kindred. Obstet Gynecol 1969;33:649-57.
  • 2 Madden JD, Walsh PC, MacDonald PC, Wilson JD. Clinical and endocrinologic characterization of a patient with the syndrome of incomplete testicular feminization. J Clin Endocrinol Metab 1975;41:751-60.
  • 3 Griffin JE, Wilson JD. The syndromes of androgen resistance. N Engl J Med 1980;302:198-209.
  • 4 Quigley CA, De Bellis A, Marschk KB, E1- Awady MK, Wilson EM, French FS. Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321.
  • 5 Brinkman AO, Jenster G, Ris-Stapers C, van der Korput JA, Brüggenwirth HT, Boehmer AL, et al. Androgen receptor mutations. J Steroid Biochem Mol Biol 1995;53:443-8.
  • 6 Berek JS. Novak′s Gynecology. 14 th Ed. New Delhi: Wolters Kluwer Health (India) Pvt. Ltd.; 2007. p. 1047-51.
  • 7 Pratap K, Narendra M. Jeffcoate′s Principles of Gynaecology. 7 th Ed. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd; 2008. p. 219-50.
  • 8 Cotran, Kumar, Robbins. Robbins Pathologic Basis of Disease, 6th Ed. Canada: W.B. Saunder Company 1999. p. 1018-23.
  • 9 Johnson DE, Appelt G, Samuels ML, Luna M. Metastasis from testicular carcinoma: Study of 78 autopsied cases. Urology 1976;8:234-9.